76% of patients think pharmaceutical companies have a responsibility to provide information and services that help patients manage their own health. Nearly as many respondents— 74%—indicate that the most appropriate time to initiate outreach is when they start taking a medication, although half of the respondents are open to receiving assistance after they have begun a course of treatment or are considering switching.
There’s a new boss in U.S. healthcare: the consumer according to a survey of 2,339 U.S. residents .The research paints a clear picture of a population displeased with its overall healthcare experience — and with rising expectations for transparency, value, and customer service, as well as a willingness to seek healthcare services from less traditional sources. The healthcare market as we know it is being upended, and the consumer is in the driver’s seat. Consumers, particularly younger ones, increasingly expect healthcare to work the way other digital markets work, with user-friendly interfaces, clearly defined pricing and wide spread options designed to meet their needs. Their other buying experiences have made them more savvy and skeptical, and they want to know what they’re getting before they spend.
Sen. Bernie Sanders and U.S. Rep. Elijah E. Cummings on Thursday launched an investigation into soaring generic drug prices. “We are conducting an investigation into the recent staggering price increases for generic drugs used to treat everything from common medical conditions to life-threatening illnesses,” Sanders, chairman of a Senate health care subcommittee, and Cummings, ranking member of the House oversight committee, wrote in letters to 14 pharmaceutical companies.
POST SUMMARY: Not only do patients have to worry about which drug company paid their physician, they need to determine if their generic drug is the same as the branded equivalent and if their insurance company will allow their doctor to write for a specific medication. What is pharma doing to help patients navigate the complex world of empowered patient choices?